Metagenomi, Inc. Common Stock (MGX) — Cash Flow-to-Debt Ratio
Metagenomi, Inc. Common Stock (MGX) has a Cash Flow-to-Debt Ratio of -0.36x as of March 2026, meaning its operating cash flow of $-21.18 Million could theoretically repay 0% of its total liabilities ($59.17 Million) in one year. See how much free cash does Metagenomi, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Metagenomi, Inc. Common Stock Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Metagenomi, Inc. Common Stock across 5 annual periods. Also explore MGX net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Metagenomi, Inc. Common Stock (2021–2025)
Year-by-year debt coverage analysis for Metagenomi, Inc. Common Stock. For market capitalisation and broader financial context, see Metagenomi, Inc. Common Stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.42x | $-88.89 Million | $62.51 Million | ▼ -17.0% |
| 2024 | -1.22x | $-109.07 Million | $89.74 Million | ▼ -99.0% |
| 2023 | -0.61x | $-91.41 Million | $149.67 Million | ▼ -1104.6% |
| 2022 | 0.06x | $29.72 Million | $488.91 Million | ▼ -56.3% |
| 2021 | 0.14x | $24.26 Million | $174.54 Million | — |